首页> 外文期刊>Proteome science >Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients
【24h】

Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients

机译:急性重症登革热患者血浆标本的同位素编码蛋白质标记分析

获取原文
获取外文期刊封面目录资料

摘要

Background Dengue fever is the most important arthropod born viral disease of public health significance. Although most patients suffer only from flu-like symptoms, a small group of patient experiences more severe forms of the disease. To contribute to a better understanding of its pathogenesis this study aims to identify proteins differentially expressed in a pool of five viremic plasma from severe dengue patients relative to a pool of five non-severe dengue patients. Results The use of Isotope Coded Protein Labeling (ICPLTM) to analyze plasma depleted of twenty high-abundance proteins allowed for the identification of 51 differentially expressed proteins, which were characterized by mass spectrometry. Using quantitative ELISA, three of these proteins (Leucine-rich glycoprotein 1, Vitamin D binding-protein and Ferritin) were confirmed as having an increased expression in a panel of severe dengue plasma. The proteins identified as overexpressed by ICPLTM in severe dengue plasma involve in clear up action after cell injury, tissue coherence and immune defense. Conclusion This ICPLTM study evaluating differences between acute severe dengue plasmas and acute non-severe dengue plasmas suggests that the three proteins identified are overexpressed early in the course of the disease. Their possible use as biomarkers for the prognostic of disease severity is discussed.
机译:背景登革热是节肢动物出生的最重要的病毒性疾病,具有公共卫生意义。尽管大多数患者仅患有流感样症状,但一小部分患者会经历更严重的疾病形式。为了更好地了解其发病机理,本研究旨在鉴定在5例严重登革热患者的病毒血症血浆相对于5例非严重登革热患者中差异表达的蛋白质。结果使用同位素编码蛋白质标记(ICPLTM)分析20种高丰度蛋白质消耗的血浆,可以鉴定51种差异表达的蛋白质,并通过质谱进行了表征。使用定量ELISA,证实了其中三种蛋白(富含亮氨酸的糖蛋白1,维生素D结合蛋白和铁蛋白)在一组严重的登革热血浆中表达增加。被ICPLTM鉴定为在严重登革热血浆中过表达的蛋白质涉及细胞损伤,组织凝聚力和免疫防御后的清除作用。结论这项ICPLTM研究评估了急性重度登革热血浆与急性非重度登革热血浆之间的差异,表明所鉴定的三种蛋白质在疾病过程的早期过表达。讨论了它们可能用作疾病严重程度预后的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号